Literature DB >> 18452966

Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever.

Anna P Durbin1, Maria José Vargas, Kimberli Wanionek, Samantha N Hammond, Aubree Gordon, Crisanta Rocha, Angel Balmaseda, Eva Harris.   

Abstract

In vitro studies have attempted to identify dengue virus (DEN) target cells in peripheral blood; however, extensive phenotyping of peripheral blood mononuclear cells (PBMCs) from dengue patients has not been reported. PBMCs collected from hospitalized children suspected of acute dengue were analyzed for DEN prM, CD32, CD86, CD14, CD11c, CD16, CD209, CCR7, CD4, and CD8 by flow cytometry to detect DEN antigen in PBMCs and to phenotype DEN-positive cells. DEN prM was detected primarily in activated monocytes (CD14(+), CD32(+), CD86(+), CD11c(+)). A subset of samples analyzed for DEN nonstructural protein 3 (NS3) confirmed that approximately half of DEN antigen-positive cells contained replicating virus. A higher percentage of PBMCs from DHF patients expressed prM, CD86, CD32, and CD11c than did those from DF patients. Increased activation of monocytes and greater numbers of DEN-infected cells were associated with more severe dengue, implicating a role for monocyte activation in dengue immunopathogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18452966      PMCID: PMC2546568          DOI: 10.1016/j.virol.2008.03.028

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  47 in total

1.  Clinical, epidemiologic, and virologic features of dengue in the 1998 epidemic in Nicaragua.

Authors:  E Harris; E Videa; L Pérez; E Sandoval; Y Téllez; M L Pérez; R Cuadra; J Rocha; W Idiaquez; R E Alonso; M A Delgado; L A Campo; F Acevedo; A Gonzalez; J J Amador; A Balmaseda
Journal:  Am J Trop Med Hyg       Date:  2000 Jul-Aug       Impact factor: 2.345

Review 2.  Dengue: an escalating problem.

Authors:  Robert V Gibbons; David W Vaughn
Journal:  BMJ       Date:  2002-06-29

3.  Prospective study of the duration and magnitude of viraemia in children hospitalised during the 1996-1997 dengue-2 outbreak in French Polynesia.

Authors:  B Murgue; C Roche; E Chungue; X Deparis
Journal:  J Med Virol       Date:  2000-04       Impact factor: 2.327

4.  B cells are the principal circulating mononuclear cells infected by dengue virus.

Authors:  A D King; A Nisalak; S Kalayanrooj; K S Myint; K Pattanapanyasat; S Nimmannitya; B L Innis
Journal:  Southeast Asian J Trop Med Public Health       Date:  1999-12       Impact factor: 0.267

5.  Human skin Langerhans cells are targets of dengue virus infection.

Authors:  S J Wu; G Grouard-Vogel; W Sun; J R Mascola; E Brachtel; R Putvatana; M K Louder; L Filgueira; M A Marovich; H K Wong; A Blauvelt; G S Murphy; M L Robb; B L Innes; D L Birx; C G Hayes; S S Frankel
Journal:  Nat Med       Date:  2000-07       Impact factor: 53.440

6.  Anti-TNF antibody treatment reduces mortality in experimental dengue virus infection.

Authors:  Alena Atrasheuskaya; Peter Petzelbauer; Terry M Fredeking; George Ignatyev
Journal:  FEMS Immunol Med Microbiol       Date:  2003-01-21

7.  Human dendritic cells as targets of dengue virus infection.

Authors:  M Marovich; G Grouard-Vogel; M Louder; M Eller; W Sun; S J Wu; R Putvatana; G Murphy; B Tassaneetrithep; T Burgess; D Birx; C Hayes; S Schlesinger-Frankel; J Mascola
Journal:  J Investig Dermatol Symp Proc       Date:  2001-12

8.  Characterisation of lymphocyte response and cytokine patterns in patients with dengue fever.

Authors:  E L Azeredo; S M Zagne; M A Santiago; A S Gouvea; A A Santana; P C Neves-Souza; R M Nogueira; M P Miagostovich; C F Kubelka
Journal:  Immunobiology       Date:  2001-12       Impact factor: 3.144

9.  Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity.

Authors:  D W Vaughn; S Green; S Kalayanarooj; B L Innis; S Nimmannitya; S Suntayakorn; T P Endy; B Raengsakulrach; A L Rothman; F A Ennis; A Nisalak
Journal:  J Infect Dis       Date:  2000-01       Impact factor: 5.226

10.  DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells.

Authors:  Boonrat Tassaneetrithep; Timothy H Burgess; Angela Granelli-Piperno; Christine Trumpfheller; Jennifer Finke; Wellington Sun; Michael A Eller; Kovit Pattanapanyasat; Suttipant Sarasombath; Deborah L Birx; Ralph M Steinman; Sarah Schlesinger; Mary A Marovich
Journal:  J Exp Med       Date:  2003-04-07       Impact factor: 14.307

View more
  91 in total

1.  Dengue hemorrhagic fever-associated immunomediators induced via maturation of dengue virus nonstructural 4B protein in monocytes modulate endothelial cell adhesion molecules and human microvascular endothelial cells permeability.

Authors:  James F Kelley; Pakieli H Kaufusi; Vivek R Nerurkar
Journal:  Virology       Date:  2011-11-29       Impact factor: 3.616

Review 2.  How innate immune mechanisms contribute to antibody-enhanced viral infections.

Authors:  Sukathida Ubol; Scott B Halstead
Journal:  Clin Vaccine Immunol       Date:  2010-09-28

3.  Maturation of dengue virus nonstructural protein 4B in monocytes enhances production of dengue hemorrhagic fever-associated chemokines and cytokines.

Authors:  James F Kelley; Pakieli H Kaufusi; Esther M Volper; Vivek R Nerurkar
Journal:  Virology       Date:  2011-08-02       Impact factor: 3.616

Review 4.  Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms.

Authors:  Alan L Rothman
Journal:  Nat Rev Immunol       Date:  2011-07-15       Impact factor: 53.106

5.  Dengue virus induces mitochondrial elongation through impairment of Drp1-triggered mitochondrial fission.

Authors:  Vincent Barbier; Diane Lang; Sierra Valois; Alan L Rothman; Carey L Medin
Journal:  Virology       Date:  2016-11-04       Impact factor: 3.616

6.  Liposome-mediated delivery of iminosugars enhances efficacy against dengue virus in vivo.

Authors:  Joanna L Miller; Ruben Lachica; Andrew C Sayce; James P Williams; Manisha Bapat; Raymond Dwek; P Robert Beatty; Eva Harris; Nicole Zitzmann
Journal:  Antimicrob Agents Chemother       Date:  2012-10-15       Impact factor: 5.191

7.  Human T Lymphocytes Are Permissive for Dengue Virus Replication.

Authors:  Guilherme F Silveira; Pryscilla F Wowk; Allan H D Cataneo; Paula F Dos Santos; Murilo Delgobo; Marco A Stimamiglio; Maria Lo Sarzi; Ana Paula F S Thomazelli; Ivete Conchon-Costa; Wander R Pavanelli; Lis R V Antonelli; André Báfica; Daniel S Mansur; Claudia N Duarte Dos Santos; Juliano Bordignon
Journal:  J Virol       Date:  2018-04-27       Impact factor: 5.103

8.  Utility of humanized BLT mice for analysis of dengue virus infection and antiviral drug testing.

Authors:  Natalia Frias-Staheli; Marcus Dorner; Svetlana Marukian; Eva Billerbeck; Rachael N Labitt; Charles M Rice; Alexander Ploss
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

9.  Cell type specificity and host genetic polymorphisms influence antibody-dependent enhancement of dengue virus infection.

Authors:  Kobporn Boonnak; Kaitlyn M Dambach; Gina C Donofrio; Boonrat Tassaneetrithep; Mary A Marovich
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

10.  Gene expression patterns of dengue virus-infected children from nicaragua reveal a distinct signature of increased metabolism.

Authors:  P'ng Loke; Samantha N Hammond; Jacqueline M Leung; Charles C Kim; Sajeev Batra; Crisanta Rocha; Angel Balmaseda; Eva Harris
Journal:  PLoS Negl Trop Dis       Date:  2010-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.